Rationality of Prices of Antineoplastic Drugs Based on Price Comparison Analysis
WANG Jingliu1, LIU Pingyu1,*, LI Xin2, HAN Feng2
1Department of Pharmacy, Second Affiliated Hospital of Nanjing Medical University, Nanjing Jiangsu 2100001; 2School of Pharmacy, Nanjing Medical University, Nanjing Jiangsu 210000, China
WANG Jingliu, LIU Pingyu, LI Xin, HAN Feng. Rationality of Prices of Antineoplastic Drugs Based on Price Comparison Analysis[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1162-1165.
[1] GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the global burden of disease study 2016BD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the global burden of disease study 2016[J]. Lancet, 2018, 391(10136): 2236-2271. [2] Wang Y.Price Theory and Price Management(价格理论与价格管理)[M]. Beijing: China Price Press, 2000. [3] Guo Y.The study of chinese drug price management model[D].Shenyang: Shenyang Pharmaceutical University, 2002. [4] Xue W.SPSS Statistical Analysis Method and Application(SPSS统计分析方法及应用)[M]. Beijing: Electronic Industry Press, 2004. [5] Lv LT, Yu LJ.Comparative study of Sino-British cancer drug policies[J]. Health Policy Research in China(中国卫生政策研究), 2019, 12(2): 16-19. [6] Rong YN.Comparison and enlightenment of outpatient medicine compensation policies in some european countries[J]. Chinese Hospital Management(中国医院管理), 2019, 39(6): 77. [7] Liu QF.The implications of the japanese drug price negotiation for China[J]. Chinese Journal of Pharmaceuticals(中国医药工业杂志), 2018, 49(10): 1477. [8] National Health Commission.2020 China Health Statistics Yearbook(2020中国卫生健康统计年鉴)[M]. Beijing: Peking Union Medical College Press, 2020. [9] Hu SL.Analysis on economics theoretical basis and impact in drug bulk purchasing with quantity[J]. Soft Science of Health(卫生软科学), 2019, 33(1): 4. [10] WHO. Meeting Report on Fair Pricing Forum[R]. Amsterdam, The Netherlands, 2017.